DK0700285T3 - Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler - Google Patents

Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler

Info

Publication number
DK0700285T3
DK0700285T3 DK94916318T DK94916318T DK0700285T3 DK 0700285 T3 DK0700285 T3 DK 0700285T3 DK 94916318 T DK94916318 T DK 94916318T DK 94916318 T DK94916318 T DK 94916318T DK 0700285 T3 DK0700285 T3 DK 0700285T3
Authority
DK
Denmark
Prior art keywords
drug
release
alpha
drug delivery
composition
Prior art date
Application number
DK94916318T
Other languages
Danish (da)
English (en)
Inventor
Nidal Farraj
Lisbeth Illum
Peter Watts
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of DK0700285T3 publication Critical patent/DK0700285T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94916318T 1993-05-29 1994-05-27 Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler DK0700285T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311191A GB9311191D0 (en) 1993-05-29 1993-05-29 Controlled release drug formulation
PCT/GB1994/001158 WO1994027582A1 (fr) 1993-05-29 1994-05-27 COMPOSITION MEDICAMENTEUSE A BASE D'AGENT BLOQUANT DU RECEPTEUR α-ADRENERGIQUE S'ADMINISTRANT ORALEMENT

Publications (1)

Publication Number Publication Date
DK0700285T3 true DK0700285T3 (da) 1999-02-15

Family

ID=10736382

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916318T DK0700285T3 (da) 1993-05-29 1994-05-27 Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler

Country Status (12)

Country Link
EP (1) EP0700285B1 (fr)
JP (1) JPH09504779A (fr)
AT (1) ATE171370T1 (fr)
AU (1) AU684786B2 (fr)
CA (1) CA2163340A1 (fr)
DE (1) DE69413534T2 (fr)
DK (1) DK0700285T3 (fr)
ES (1) ES2124889T3 (fr)
FI (1) FI955730A (fr)
GB (2) GB9311191D0 (fr)
NO (1) NO306759B1 (fr)
WO (1) WO1994027582A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
FR2752737B1 (fr) * 1996-08-29 1998-10-02 Synthelabo Comprime a liberation controlee de chlorhydrate d'alfuzosine
NZ334018A (en) * 1996-08-29 1999-06-29 Synthelabo Multilayered controlled release tablet comprising a layer of alfuzosin hydrochloride and at least one layer of hydrophillic polymers
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US6749867B2 (en) 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1366761A4 (fr) * 2001-02-13 2004-04-21 Taisho Pharmaceutical Co Ltd Preparations de gel a usage interne
US20060147530A1 (en) * 2002-10-22 2006-07-06 Viswanathan Narayanan B Sustained release compositions containing alfuzosin
US8206742B2 (en) 2006-01-12 2012-06-26 Wockhardt Ltd. Sustained release compositions of alfuzosin
US20070292505A1 (en) * 2006-06-15 2007-12-20 Abrika Pharmaceuticals, Inc. Controlled release alfuzosin hydrochloride formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
GB2292315B (en) 1997-04-02
EP0700285B1 (fr) 1998-09-23
CA2163340A1 (fr) 1994-12-08
AU684786B2 (en) 1998-01-08
GB2292315A (en) 1996-02-21
NO306759B1 (no) 1999-12-20
WO1994027582A1 (fr) 1994-12-08
NO954583L (no) 1995-11-14
JPH09504779A (ja) 1997-05-13
NO954583D0 (no) 1995-11-14
AU6802094A (en) 1994-12-20
DE69413534D1 (de) 1998-10-29
GB9311191D0 (en) 1993-07-14
ES2124889T3 (es) 1999-02-16
DE69413534T2 (de) 1999-03-18
ATE171370T1 (de) 1998-10-15
GB9523191D0 (en) 1996-01-17
EP0700285A1 (fr) 1996-03-13
FI955730A0 (fi) 1995-11-28
FI955730A (fi) 1996-01-26

Similar Documents

Publication Publication Date Title
DK0817621T4 (da) Farmaceutisk filmdannende sammensætning til transdermal administration
DK0700285T3 (da) Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler
PT1028707E (pt) Formulacoes oftalmicas de libertacao controlada contendo medicamentos soluveis em agua
NZ314442A (en) Extended release formulation comprising venlafaxine hydrochloride, film coating composition
DE60233898D1 (de) Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin-plasmaspiegeln
ID29994A (id) Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida
FI954228A (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
YU36700A (sh) Oralni farmaceutski oblik za doziranje sa produženim oslobađanjem
MX9701465A (es) Formulacion de acetaminofeno, de liberacion sostenida.
CO5130022A1 (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial
AU2084801A (en) Antiviral medication
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
IL154731A0 (en) Ion-strength independent sustained release pharmaceutical formulation
NL193820B (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
ATE276768T1 (de) Arzneimittel gegen hepatitis
WO2002028424A3 (fr) Cybermedicament utilise comme autovaccins avec effets d'immunoregulation
LT96093A (en) The active ingredient of pharmaceutical composition for treating aphtae and stomatitis
ATE205204T1 (de) Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
FR2821080B1 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques
AU6869996A (en) Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them
HUP0104968D0 (en) Transdermal pharmaceutical composition containing aspirine for the treatment of sclerosis
PL301249A1 (en) Application of iphosphamide as an anticarcinogenic drug
SI0859595T1 (en) Therapeutic preparation for the transdermal administration of active substances
MX9704847A (es) Material de relleno para forma de dosis farmaceutica de gelatina blanda.